Celldex Therapeutics, Inc.
2021 Q2 - 2025 Q4 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 2,007 | 0.0% | 75,130 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 2,535 | 0.0% | 124,546 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,720 | 0.0% | 94,785 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,638 | 0.0% | 104,376 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 3,595 | 0.0% | 105,777 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 4,803 | 0.0% | 129,787 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 5,437 | 0.0% | 129,544 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,722 | 0.0% | 43,427 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 1,371 | 0.0% | 49,832 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,532 | 0.0% | 45,166 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,198 | 0.0% | 61,078 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 2,633 | 0.0% | 58,651 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 1,540 | 0.0% | 54,464 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 1,379 | 0.0% | 50,133 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 2,187 | 0.0% | 63,511 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 903 | 0.0% | 23,286 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,262 | 0.0% | 23,379 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 740 | 0.0% | 22,135 | 6/30/2021 |